JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups

  • 0Pathology Department, College of Medicine, King Khalid University, Abha.
European Journal of Histochemistry : Ejh +

|

February 11, 2025

|

February 11, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

AMACR and ERG immunostains are valuable tools for diagnosing prostate cancer (PCa) and predicting its prognosis. Their utility is enhanced when used alongside grading systems, improving diagnostic accuracy and patient outcomes.

Area Of Science

  • Uropathology
  • Cancer Biomarkers
  • Immunohistochemistry

Background

  • Accurate diagnosis and prognostication of prostatic adenocarcinoma (PCa) are crucial for patient management.
  • Traditional grading systems like Gleason score and WHO grading groups have limitations in assessing PCa aggressiveness.
  • Immunohistochemical markers offer potential for refining PCa diagnosis and prognosis.

Purpose Of The Study

  • To evaluate the diagnostic and prognostic utility of AMACR, ERG, and AR immunostains in PCa.
  • To compare the performance of these markers against Gleason score and WHO grading groups.
  • To determine the sensitivity and specificity of AMACR and ERG in PCa detection.

Main Methods

  • Analysis of 17 PCa and 5 benign prostatic hyperplasia (BPH) biopsies.
  • Immunoreactivity scoring (1-3) based on percentage and intensity of positive cells for AMACR, ERG, and AR.
  • Correlation of marker expression with PCa grade groups and comparison with Gleason scores.

Main Results

  • High positivity rates for AMACR (76.47%), ERG (35.29%), and AR (94.12%) in PCa cases.
  • AMACR demonstrated notable sensitivity, while ERG showed significant specificity for PCa.
  • Increased positivity for AMACR and ERG correlated with higher PCa grade groups, indicating prognostic value.

Conclusions

  • AMACR and ERG immunostains are sensitive and specific markers aiding in PCa diagnosis and prognostication.
  • The increasing expression of AMACR and ERG with higher tumor grades highlights their prognostic significance.
  • Immunostains like AMACR and ERG are valuable adjuncts for refining PCa diagnosis and improving prognostic assessment.